Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients

Table 1

The relationships of demographic features and comparison of serum parathormone levels with fibroblast growth factor-23, calcium, and phosphorus in the dialysis patients.

	PTH < 300 pg/mL	PTH > 300 pg/mL
Age; mean ± SD	47,94,21	46,8,57	0,394
Gender; (%)
Male	17 (51,50)	24 (42,90)	0,506
Female	16 (48,50)	32 (57,10)
Dialysis duration (years); mean ± SD	3,0,91	4,7,03	0,587
Etiology; (%)
Hypertension	14 (42,40)	25 (44,70)	0,923
Postrenal KBH	7 (21,30)	7 (12,50)
Glomerulonephritis	12 (36,40)	23 (41,10)
Unknown	—	1 (1,80)
(ng/mL); mean ± SD	159,,66	741,,77	0,001 **
Calcium (mg/dL); mean ± SD	8,6,99	8,5,93	0,871
Phosphorus (mg/dL); mean ± SD	4,3,07	5,6,54	0,0001
Ca*P (mg^2/dL^2) mean ± SD	37,,61	48,,75	0,001

Data are presented as (%). PTH: parathormone; KBH: chronic renal diseases; : fibroblast growth factor; Ca: calcium; P: phosphorus.
Statistical significance positive correlation (,01).